{
    "2020-11-27": [
        [
            {
                "time": "",
                "original_text": "药明康德获摩根大通增持52.60万股，涉资约6281.74万港元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "摩根大通",
                        "增持",
                        "52.60万股",
                        "6281.74万港元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【权益变动】药明康德(02359-HK)获摩根大通增持52.5989万股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "摩根大通",
                        "增持",
                        "52.5989万股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德现1笔大宗交易 共成交3,738.90万元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "大宗交易",
                        "3,738.90万元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【权益变动】药明康德(02359-HK)被摩根大通减持17.7435万股 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "摩根大通",
                        "减持",
                        "17.7435万股"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【泰有财·研究服务】医药行业点评",
                "features": {
                    "keywords": [
                        "医药行业",
                        "点评"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}